A evolução do mercado farmacêutico brasileiro no tratamento do glaucoma nos últimos 30 anos

Related authors

• João Pessoa de Souza Filho
• Ana Beatriz Toledo Dias
• Acácio Alves de Souza Lima Filho
• Marta Filippi Sartori
• Maria Cristina Martins

Related articles

• Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis
• Evaluation of microbial contamination in multi-dose fluorescein eyedrops in a reference eye center
• Mass variability in drops of multidose eyedrops: a quality and reliability study
• The real cost of glaucoma treatment for an outpatient
• Use of machine learning to predict the risk of early morning intraocular pressure peaks in glaucoma patients and suspects
• Phacoemulsification with Kahook Dual Blade goniotomy in eyes with medically treated glaucoma: analysis of surgical outcomes and success predictors
• Pars plana vitrectomy combined with pan-retinal photocoagulation, Ahmed glaucoma valve implantation, and/or phacoemulsification for complicated neovascular glaucoma treatment
• Comparison of the efficacy of latanoprost versus dorzolamide/timolol fixed combination therapy in patients with pseudoexfoliative glaucoma according to glaucoma stage
• Trabecular microbypass as replacement therapy in pharmacologically controlled open-angle glaucoma patients
• TXNRD2 (rs35934224) CT genotype as possible protective marker for primary open-angle glaucoma in a Brazilian population

Click here to search